Kempner Capital Management’s CONMED CNMD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
$252K Sell
6,258
-43,296
-87% -$1.88M 0.24% 42
2025
Q3
$2.33M Sell
49,554
-43,920
-47% -$2.28M 1.94% 25
2025
Q2
$4.87M Hold
93,474
2.61% 19
2025
Q1
$5.64M Hold
93,474
3.18% 11
2024
Q4
$6.4M Hold
93,474
3.51% 5
2024
Q3
$6.72M Hold
93,474
3.44% 4
2024
Q2
$6.48M Buy
+93,474
New +$6.82M 3.44% 7

Other funds holding CNMD

Kempner Capital Management's CNMD Position: Q4 2025 in Review

Kempner Capital Management reduced its CONMED (CNMD) stake by 87% in Q4 2025, selling an estimated $1.88M and leaving 6,258 shares worth $252K. The position accounts for 0.24% of the portfolio, ranked #42.

Kempner Capital Management first reported a position in CNMD in Q2 2024 and has held it in 7 quarters since. The position peaked at $6.72M in Q3 2024. 265 funds tracked by Wall St. Rank hold CNMD as of Q4 2025.

  • Kempner Capital Management held 6,258 shares of CONMED worth $252K as of Q4 2025.
  • Kempner Capital Management sold 43,296 CONMED shares in Q4 2025, an estimated $1.88M.
  • CONMED made up 0.24% of Kempner Capital Management's portfolio in Q4 2025, its #42 holding.
  • Kempner Capital Management first reported a position in CONMED in Q2 2024 and has held it in 7 quarters since.
  • Kempner Capital Management's CONMED position peaked at $6.72M in Q3 2024.
  • 265 funds tracked by Wall St. Rank held CONMED as of Q4 2025.

Based on Kempner Capital Management's 13F filing for Q4 2025, filed 12 Jan 2026.